Sources | Names Used |
---|---|
CTRPv2 | salermide:PLX-4032 (12:1 mol/mol) |
PharmacoGx | salermide:PLX-4032 (12:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WAPL | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
mRNA | FUNDC2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | PLEKHG6 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
mRNA | TAF5L | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
mRNA | UBE2Q2L | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
mRNA | TTC7A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
mRNA | DISP2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
mRNA | SGK1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
mRNA | NRG3 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | GUCY1A2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |